Neuroquiescence—a treatment for neurodevelopmental and neurodegenerative bioelectrical dysregulation and demyelination
AssigneesDebora Zucco Sassi Yonezawa Siviglia, Gary Aaron Howard
InventorsDebora Zucco Sassi Yonezawa Siviglia, Gary Aaron Howard
Life of this patent
Estimating the term…
Abstract
The present inventive concept defines as “Neuroquiescence” a method for treating neurovascular dysregulation underlying neurodevelopmental and neurodegenerative dysfunctions by improving immunovascular robustness for fueling glial cells while pausing neuronal bioelectrical activity for remyelination and astrocyte resetting cellular homeostasis.
Claims19
A method for reducing neuronal agitation and cellular oxygenation deficiencies in a subject in need thereof comprising administering a therapeutic amount of Dobutamine to improve microvasculature transport of bloodflow.
A method for enabling remyelination and neurological repairs in a subject in need thereof comprising:
- medically sedating the subject for a minimum of three days by administering a therapeutically effective amount of an anesthetic,
- wherein medically sedating the subject pauses bioelectrical activity of neurons in the subject to facilitate systemic repair of the neurons in the subject.
Dependencies are inferred from the claim text.